(Q43244116)

17 November 2017

Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone (English)

1 reference

17 November 2017

4

1 reference

17 November 2017

Ilaria Miceli

1

1 reference

17 November 2017

Davina Burt

2

1 reference

17 November 2017

Elena Tarabra

3

1 reference

17 November 2017

Paolo Cavallo Perin

5

1 reference

17 November 2017

Gabriella Gruden

6

1 reference

17 November 2017

11 November 2009

1 reference

American Journal of Physiology - Renal Physiology

17 November 2017

1 reference

17 November 2017

298

1 reference

17 November 2017

2

1 reference

17 November 2017

F381-90

1 reference

Rosiglitazone reduces urinary albumin excretion in type II diabetes

17 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/AKT-signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Stable cell line of T-SV40 immortalized human glomerular visceral epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Activation of a local tissue angiotensin system in podocytes by mechanical strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Activation of a local renin angiotensin system in podocytes by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Nephrin localizes to the slit pore of the glomerular epithelial cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Expression of nephrin in acquired human glomerular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Peroxisome proliferator-activated receptor gamma agonists in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Functional expression of the renin-angiotensin system in human podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Effects of monotherapy of temocapril or candesartan with dose increments or combination therapy with both drugs on the suppression of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Cell biology of the glomerular podocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Nephrin is specifically located at the slit diaphragm of glomerular podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Thiazolidinedione derivatives ameliorate albuminuria in streptozotocin-induced diabetic spontaneous hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

Transcriptional Regulation of Nephrin Gene by Peroxisome Proliferator-Activated Receptor- Agonist: Molecular Mechanism of the Antiproteinuric Effect of Pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90423.2008

10.1152/AJPRENAL.90423.2008

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference